Improved Clinical Data Reporting Supports NHS Goals for UK Cancer Care
By MedImaging International staff writers Posted on 16 Feb 2011 |
Two initiatives have been completed aimed at streamlining the input of clinical data in the UK's National Health Service (NHS).
Varian Medical Systems' (Palo Alto, CA, USA) Aria for MedOncology information system is now compatible with the National Cancer Intelligences Network (NCIN)/National Chemotherapy Advisory Group (NCAG) draft dataset, and the Chemotherapy Planning Online Resource Tool (C-PORT).
"Far too much staff time in UK hospitals has been taken up inputting clinical data into different systems and there has been much duplication of effort, as they often need to manually input the same data two or three times," stated Bev McParland, area software sales manager for Varian Medical Systems. "The National Health Service is attempting to address this by introducing streamlined systems and Varian has worked hard to ensure our oncology information system is compatible with these. Aria medical oncology customers will receive these reports as part of their standard upgrade program. The upshot should be that clinical staff can spend less time inputting data and more time caring for patients."
The new draft NCIN dataset along with the existing reporting tools for radiotherapy will provide all stakeholders with the information to measure patient outcomes in real time, plan for future facilities, and adjust funding based on accurate and timely data. To ensure compatibility with this draft dataset, Varian received support from two key customer facilities that acted as pilot sites (Thames Valley and Lancashire Cancer Network), along with advice and support from the National Cancer Action Team (NCAT) and National Cancer Intelligence Network.
Developed for the NHS (Leeds, UK) by Concentra (Addison, TX, USA), the C-PORT system is on on-line tool that applies advanced modeling techniques to tackle the problem of chemotherapy capacity planning. Available to all NHS hospitals, it enables them to produce a "model" of an entire cancer center, including staff, equipment and overhead. By inputting all these resources, administrators can calculate the financial and efficiency implications of changes in staffing or equipment.
"Manually inputting data from your oncology information system into C-PORT is very time-consuming, which is why Varian has created an interface between our Aria system and C-PORT," said Steve Laws, Varian's head of European software sales. "The NHS understands that by properly modeling resources they can spend money in the right way and achieve cost-efficiencies and we are working hard to ensure our systems interface effectively with these tools. With the government's comprehensive spending review, the emphasis is on efficiency savings within the NHS to fund future investment, and these systems play their part in driving those efficiency savings."
Jane Whittome, associate director of NCAT, said, "We are really pleased to have worked with Varian as they have supported clinical teams in the NHS by ensuring that their products are able to interface with CPORT making data entry easier and quicker and also ensuring that their e-prescribing system is compatible with the draft dataset, so that once collection of the datasets is mandatory, NHS Trusts who use their system will more easily be able to submit data."
Related Links:
UK National Health Service
Varian Medical Systems
Concentra
Varian Medical Systems' (Palo Alto, CA, USA) Aria for MedOncology information system is now compatible with the National Cancer Intelligences Network (NCIN)/National Chemotherapy Advisory Group (NCAG) draft dataset, and the Chemotherapy Planning Online Resource Tool (C-PORT).
"Far too much staff time in UK hospitals has been taken up inputting clinical data into different systems and there has been much duplication of effort, as they often need to manually input the same data two or three times," stated Bev McParland, area software sales manager for Varian Medical Systems. "The National Health Service is attempting to address this by introducing streamlined systems and Varian has worked hard to ensure our oncology information system is compatible with these. Aria medical oncology customers will receive these reports as part of their standard upgrade program. The upshot should be that clinical staff can spend less time inputting data and more time caring for patients."
The new draft NCIN dataset along with the existing reporting tools for radiotherapy will provide all stakeholders with the information to measure patient outcomes in real time, plan for future facilities, and adjust funding based on accurate and timely data. To ensure compatibility with this draft dataset, Varian received support from two key customer facilities that acted as pilot sites (Thames Valley and Lancashire Cancer Network), along with advice and support from the National Cancer Action Team (NCAT) and National Cancer Intelligence Network.
Developed for the NHS (Leeds, UK) by Concentra (Addison, TX, USA), the C-PORT system is on on-line tool that applies advanced modeling techniques to tackle the problem of chemotherapy capacity planning. Available to all NHS hospitals, it enables them to produce a "model" of an entire cancer center, including staff, equipment and overhead. By inputting all these resources, administrators can calculate the financial and efficiency implications of changes in staffing or equipment.
"Manually inputting data from your oncology information system into C-PORT is very time-consuming, which is why Varian has created an interface between our Aria system and C-PORT," said Steve Laws, Varian's head of European software sales. "The NHS understands that by properly modeling resources they can spend money in the right way and achieve cost-efficiencies and we are working hard to ensure our systems interface effectively with these tools. With the government's comprehensive spending review, the emphasis is on efficiency savings within the NHS to fund future investment, and these systems play their part in driving those efficiency savings."
Jane Whittome, associate director of NCAT, said, "We are really pleased to have worked with Varian as they have supported clinical teams in the NHS by ensuring that their products are able to interface with CPORT making data entry easier and quicker and also ensuring that their e-prescribing system is compatible with the draft dataset, so that once collection of the datasets is mandatory, NHS Trusts who use their system will more easily be able to submit data."
Related Links:
UK National Health Service
Varian Medical Systems
Concentra
Latest Imaging IT News
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
- Digital Pathology Software Improves Workflow Efficiency
- Patient-Centric Portal Facilitates Direct Imaging Access
- New Workstation Supports Customer-Driven Imaging Workflow
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more